Acetaminophen-d4
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Acetaminophen-d4
Description :
Acetaminophen-d4 is the deuterium labeled Acetaminophen. Acetaminophen (Paracetamol) is a selective cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 25.8 μM; is a widely used antipyretic and analgesic agent[1][2][3]. Acetaminophen is a potent hepatic N-acetyltransferase 2 (NAT2) inhibitor[4].Product Name Alternative :
Paracetamol-d4; 4-Acetamidophenol-d4; 4'-Hydroxyacetanilide-d4UNSPSC :
12352005Hazard Statement :
H302, H312, H332Target :
COX; Endogenous Metabolite; Histone AcetyltransferaseType :
Isotope-Labeled CompoundsRelated Pathways :
Epigenetics; Immunology/Inflammation; Metabolic Enzyme/ProteaseField of Research :
Inflammation/ImmunologyPurity :
99.60Solubility :
DMSO : ≥ 100 mg/mLSmiles :
OC1=C(C([2H])=C(C([2H])=C1[2H])NC(C)=O)[2H]Molecular Formula :
C8H5D4NO2Molecular Weight :
155.19Precautions :
H302, H312, H332References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Hinz, B, et al. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J, 2008. 22 (2) : p. 383-90.|[3]Miroslav Dinić, et al. Lactobacillus fermentum Postbiotic-induced Autophagy as Potential Approach for Treatment ofAcetaminophen Hepatotoxicity. Front Microbiol. 2017 Apr 6;8:594.|[4]Uchida NS, et al. Hepatoprotective Effect of Citral on Acetaminophen-Induced Liver Toxicity in Mice. Evid Based Complement Alternat Med. 2017;2017:1796209.|[5]Rothen JP, et al. Acetaminophen is an inhibitor of hepatic N-acetyltransferase 2 in vitro and in vivo. Pharmacogenetics. 1998 Dec;8 (6) :553-9.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedCAS Number :
[64315-36-2]

